Gilead Hints at Remdesivir’s Potential as a COVID-19 Treatment
- Gilead Sciences recently found that using remdesivir as a COVID-19 treatment for severe coronavirus patients produced positive results in a Phase 3 clinical trial. Severe coronavirus patients receiving a ten-day treatment of remdesivir achieved similar clinical improvement compared with those taking a five-day treatment course, the company announced...
